These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11018244)

  • 41. The correlation between admission blood glucose and intravenous rt-PA-induced arterial recanalization in acute ischemic stroke: a multi-centre TCD study.
    Saqqur M; Shuaib A; Alexandrov AV; Sebastian J; Khan K; Uchino K
    Int J Stroke; 2015 Oct; 10(7):1087-92. PubMed ID: 26332252
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
    JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.
    Ferguson JJ; Califf RM; Antman EM; Cohen M; Grines CL; Goodman S; Kereiakes DJ; Langer A; Mahaffey KW; Nessel CC; Armstrong PW; Avezum A; Aylward P; Becker RC; Biasucci L; Borzak S; Col J; Frey MJ; Fry E; Gulba DC; Guneri S; Gurfinkel E; Harrington R; Hochman JS; Kleiman NS; Leon MB; Lopez-Sendon JL; Pepine CJ; Ruzyllo W; Steinhubl SR; Teirstein PS; Toro-Figueroa L; White H;
    JAMA; 2004 Jul; 292(1):45-54. PubMed ID: 15238590
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Antithrombotic treatment in acute ischemia stroke].
    Díez-Tejedor E; Alonso de Leciñana M; Counsell C; Sandercock P
    Neurologia; 1995 Dec; 10 Suppl 2():48-54. PubMed ID: 8714450
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Organization to Assess Strategies for Ischemic Syndromes (OASIS) Pilot Study: evaluation of acute and long-term therapies for patients with acute coronary syndromes without ST elevation.
    Anand SS
    Am J Cardiol; 1999 Sep; 84(5A):13M-19M. PubMed ID: 10505538
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quality of life after ischemic stroke varies in western countries: data from the tinzaparin in Acute Ischaemic Stroke Trial (TAIST).
    Sprigg N; Gray LJ; Bath PM; Christensen H; De Deyn PP; Leys D; O'Neill D; Ringelstein EB;
    J Stroke Cerebrovasc Dis; 2012 Oct; 21(7):587-93. PubMed ID: 21388828
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antithrombotic and hypofibrinogenetic therapy in acute ischemic stroke: what is the next step?
    Sherman DG
    Cerebrovasc Dis; 2004; 17 Suppl 1():138-43. PubMed ID: 14694291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect and safety of the antithrombotic therapies in patients with atrial fibrillation and CHADS score 1.
    Lee BH; Park JS; Park JH; Park JS; Kwak JJ; Hwang ES; Kim SK; Choi DH; Kim YH; Pak HN
    J Cardiovasc Electrophysiol; 2010 May; 21(5):501-7. PubMed ID: 20021521
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety and Efficiency of Low Dose Intra-arterial Tirofiban in Mechanical Thrombectomy During Acute Ischemic Stroke.
    Yu T; Lin Y; Jin A; Zhang P; Zhou X; Fang M; Liu X
    Curr Neurovasc Res; 2018; 15(2):145-150. PubMed ID: 29875001
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Intravenously administered acetylsalicylic acid in combination with low-dose heparin in acute ischemic stroke: a safety analysis.
    Büttner T; Hellwig K; Müller T; Kuhn W
    Clin Neuropharmacol; 1998; 21(1):48-51. PubMed ID: 9579285
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association between arterial calcifications and nonlacunar and lacunar ischemic strokes.
    van Dijk AC; Fonville S; Zadi T; van Hattem AM; Saiedie G; Koudstaal PJ; van der Lugt A
    Stroke; 2014 Mar; 45(3):728-33. PubMed ID: 24457294
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recurrent Ischemic Lesions After Acute Atherothrombotic Stroke: Clopidogrel Plus Aspirin Versus Aspirin Alone.
    Hong KS; Lee SH; Kim EG; Cho KH; Chang DI; Rha JH; Bae HJ; Lee KB; Kim DE; Park JM; Kim HY; Cha JK; Yu KH; Lee YS; Lee SJ; Choi JC; Cho YJ; Kwon SU; Kim GM; Sohn SI; Park KY; Kang DW; Sohn CH; Lee J; Yoon BW;
    Stroke; 2016 Sep; 47(9):2323-30. PubMed ID: 27418597
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Randomized multicenter control clinical study on acute ischemic stroke treatment with traditional Chinese medicine].
    Cai YF; Fu Y; Guo JW; You JS; Wang LX; Liang WX; Huang Y; Huang PX
    Zhong Yao Cai; 2007 Sep; 30(9):1192-5. PubMed ID: 18236764
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of Renal Impairment on Outcome for Thrombolysis-Treated Acute Ischemic Stroke: ENCHANTED (Enhanced Control of Hypertension and Thrombolysis Stroke Study) Post Hoc Analysis.
    Carr SJ; Wang X; Olavarria VV; Lavados PM; Rodriguez JA; Kim JS; Lee TH; Lindley RI; Pontes-Neto OM; Ricci S; Sato S; Sharma VK; Woodward M; Chalmers J; Anderson CS; Robinson TG;
    Stroke; 2017 Sep; 48(9):2605-2609. PubMed ID: 28739832
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Antithrombotic therapy for ischemic cerebrovascular accident].
    Mas JL
    Arch Mal Coeur Vaiss; 2002 Nov; 95 Spec No 7():53-7. PubMed ID: 12500606
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neurological outcomes in patients with ischemic stroke receiving enoxaparin or heparin for venous thromboembolism prophylaxis: subanalysis of the Prevention of VTE after Acute Ischemic Stroke with LMWH (PREVAIL) study.
    Kase CS; Albers GW; Bladin C; Fieschi C; Gabbai AA; O'Riordan W; Pineo GF;
    Stroke; 2009 Nov; 40(11):3532-40. PubMed ID: 19696423
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
    Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effects of the results of randomized trials on the tactics of management of patients with acute stroke].
    Warlow C
    Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(2):47-50. PubMed ID: 10081136
    [No Abstract]   [Full Text] [Related]  

  • 59. Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial.
    de Lemos JA; Blazing MA; Wiviott SD; Brady WE; White HD; Fox KA; Palmisano J; Ramsey KE; Bilheimer DW; Lewis EF; Pfeffer M; Califf RM; Braunwald E;
    Eur Heart J; 2004 Oct; 25(19):1688-94. PubMed ID: 15451146
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FPIN's clinical inquiries. Aspirin in patients with acute ischemic stroke.
    Park MK; Smith PC; Wanserski G; Neher JO
    Am Fam Physician; 2009 Feb; 79(3):226-7. PubMed ID: 19202970
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.